Skip to main content
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,700.00
+13.80 (0.82%)
May 13, 2025, 3:29 PM IST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Mar '24 Mar '23 Mar '22 Mar '21
India Formulations
164.18B
Log In
Log In
Log In
Log In
India Formulations Growth
12.87%
Log In
Log In
Log In
Log In
US Formulations
161.74B
Log In
Log In
Log In
Log In
US Formulations Growth
8.34%
Log In
Log In
Log In
Log In
Total Formulations
488.44B
Log In
Log In
Log In
Log In
Total Formulations Growth
9.67%
Log In
Log In
Log In
Log In
Active Pharmaceutical Ingredients (API)
20.12B
Log In
Log In
Log In
Log In
Active Pharmaceutical Ingredients (API) Growth
6.56%
Log In
Log In
Log In
Log In
Others Segment
1.83B
Log In
Log In
Log In
Log In
Others Segment Growth
-25.38%
Log In
Log In
Log In
Log In
Emerging Market
91.95B
Log In
Log In
Log In
Log In
Emerging Market Growth
9.39%
Log In
Log In
Log In
Log In
Rest of the World Formulations
70.58B
Log In
Log In
Log In
Log In
Rest of the World Formulations Growth
6.00%
Log In
Log In
Log In
Log In
Other Operating
5.64B
Log In
Log In
Log In
Log In
Other Operating Growth
-27.19%
Log In
Log In
Log In
Log In

Other

Fiscal year is April - March.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Mar '24 Mar '23 Mar '22 Mar '21
Sales per Medical Representative
Log In
Log In
Log In
Log In
Sales per Medical Representative Growth
Log In
Log In
Log In
Log In
Number of Medical Representatives
Log In
Log In
Log In
Log In
Number of Medical Representatives Growth
Log In
Log In
Log In
Log In